Cutaneous Metastasis Originating from Prostate Adenocarcinoma

1991 ◽  
Vol 30 (5) ◽  
pp. 363-363 ◽  
Author(s):  
Ricardo B. Rossetti ◽  
Cassio M. Villaca Neto ◽  
Luiz H. C. Paschoal ◽  
Miguel Burnler
2008 ◽  
Vol 33 (1) ◽  
pp. 67-67
Author(s):  
O.H. Iwenofu ◽  
R.N. Sawh ◽  
J.V. Pitha ◽  
S.A. Lightfoot

2021 ◽  
Vol 66 (1) ◽  
pp. 113
Author(s):  
AylinTürel Ermertcan ◽  
Tubanur Çetinarslan ◽  
Peyker Temiz ◽  
Talha Müezzinoğlu

2020 ◽  
Vol 2020 ◽  
pp. 1-5
Author(s):  
Idriss Ziani ◽  
Zayd El Boukili El Makhoukh ◽  
Ahmed Ibrahimi ◽  
Omar Bellouki ◽  
Jihane Benahmed ◽  
...  

Introduction. Prostate cancer is the most common cancer in men. Cutaneous metastasis from prostate cancer is an unusual clinical finding. Scrotal skin metastasis revealing a prostate adenocarcinoma is even rarer. Case Report. We report the case of a 78-year-old patient, who initially consulted for nonspecific scrotal skin lesions evolving for 4 months. Patient’s past history revealed urinary disorders. Physical examination and PSA levels led to perform a prostate biopsy, and the diagnosis of prostate adenocarcinoma was made. Bone scintigraphy showed that the cancer has spread to the bones. Imaging studies showed that the cutaneous lesions were limited to the scrotal wall. Cutaneous metastasis was suspected and was proven on skin biopsy. The patient received second-generation hormone therapy with good clinical and biological outcomes. Discussion. Based on literature review of nearly 2,500 skin metastases, we found that only 436 were spreading from the genitourinary tract. Skin metastasis from prostate adenocarcinoma is a rare entity with a low incidence rate (0.36%). Conclusion. Skin metastases, and especially in the scrotum, are exceptional in prostate cancer. However, in any patient with a prostate adenocarcinoma, nonspecific cutaneous lesions should lead to perform skin biopsy in order to identify and initiate treatment of cutaneous metastases.


Author(s):  
A. Hakam ◽  
J.T. Gau ◽  
M.L. Grove ◽  
B.A. Evans ◽  
M. Shuman ◽  
...  

Prostate adenocarcinoma is the most common malignant tumor of men in the United States and is the third leading cause of death in men. Despite attempts at early detection, there will be 244,000 new cases and 44,000 deaths from the disease in the United States in 1995. Therapeutic progress against this disease is hindered by an incomplete understanding of prostate epithelial cell biology, the availability of human tissues for in vitro experimentation, slow dissemination of information between prostate cancer research teams and the increasing pressure to “ stretch” research dollars at the same time staff reductions are occurring.To meet these challenges, we have used the correlative microscopy (CM) and client/server (C/S) computing to increase productivity while decreasing costs. Critical elements of our program are as follows:1) Establishing the Western Pennsylvania Genitourinary (GU) Tissue Bank which includes >100 prostates from patients with prostate adenocarcinoma as well as >20 normal prostates from transplant organ donors.


1972 ◽  
Vol 105 (6) ◽  
pp. 862-868 ◽  
Author(s):  
M. H. Brownstein
Keyword(s):  

2016 ◽  
Vol 5 (1) ◽  
pp. 68
Author(s):  
Swapna Jilla ◽  
Archana Prathipati ◽  
Rashmi Patnayak ◽  
S Sarala ◽  
MS Venkata Rami Reddy

1994 ◽  
Vol 56 (4) ◽  
pp. 740-743
Author(s):  
Yuhei INOU ◽  
Minoru MIYASATO ◽  
Yoichiro SASAI

Sign in / Sign up

Export Citation Format

Share Document